| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |